Skip to main content
PulseWire News
PoliticsEurope

Court Ruling Enhances Transparency on E.U. Vaccine Negotiations

E.U. judges rule in favor of The New York Times, demanding transparency in Covid vaccine contract communications.

By Jeanna SmialekSource: nytimes.com1 min read
Court Ruling Enhances Transparency on E.U. Vaccine Negotiations
Image via nytimes.com

In brief

A recent court ruling reinforces the public's right to access communications related to Covid-19 vaccine negotiations between the E.U. and pharmaceutical companies.

In a landmark decision delivered on Wednesday, the General Court of the European Union in Luxembourg sided with The New York Times in a case concerning transparency in public records. The court determined that the European Commission must disclose text messages exchanged between Ursula von der Leyen, the Commission's president, and Pfizer CEO Albert Bourla during their discussions for a Covid-19 vaccine contract.The heart of the issue revolved around whether the text messages in question could be classified as "documents" under E.U. law that ought to be preserved and potentially made available to the public. The Commission had initially maintained that these messages were merely "short-lived" and therefore not subject to transparency regulations.However, the judges emphasized that the Commission cannot simply claim that it lacks the requested documents without providing cogent explanations that clarify the absence of such records. They remarked, “The commission has also failed to explain in a plausible manner why it considered that the text messages exchanged in the context of the procurement of Covid-19 vaccines did not contain important information.”The case was initiated in 2023 by The New York Times, amplifying the ongoing conversation surrounding governmental accountability and transparency amidst significant global health decisions. This ruling is likely to influence how public interest matters are handled in the future within the European Union, potentially paving the way for more extensive scrutiny of governmental dealings with private corporations.

Topics

More on this story